World Health Organization (WHO) top executives have confirmed that everyone who receives the monkeypox vaccine is part of a “clinical trial” to gather information about whether shots are effective.
Comments were made when agency secretary Tedros Adhanom Gebreyes dismissed the WHO advisory board and declared monkeypox a global health emergency, the agency’s highest level warning. The last such emergency was issued by WHO in early 2020 when it made the same declaration for COVID-19.
Tim Nguyen, head of the WHO Infectious Disease Control Agency, said the monkeypox vaccine has never been used on a large scale and its effectiveness is unknown.
“I would like to emphasize one thing that is very important to WHO. There is uncertainty about the effectiveness of these vaccines as they have never been used in this situation or on this scale. “Nguyen said on Saturday.
Nguyen then said, “When these vaccines are offered, they will be offered in the context of clinical trial studies and we will positively collect this data to gain a better understanding of the efficacy of these vaccines.”
Case
So far this year, more than 16,000 monkeypox cases have occurred in more than 75 countries and five people have died in Africa. The viral disease is a recent outbreak outside of Africa where it is endemic and is predominantly spread to homosexual men.
In declaring an emergency, Gebreez said, “For now, this is an outbreak that is concentrated on homosexuals and” especially those with multiple sexual partners. ” Prior to 2022, the virus was primarily displaced to western and central Africa.
according to The Food and Drug Administration has approved two vaccines for monkeypox to the US Centers for Disease Control and Prevention (CDC). ACAM2000 and JYNNEOS known as Imvamune or Imvanex.
According to authorities, many cases of monkeypox in the United States are in New York City. The city’s health agency said it had obtained more JYNNEOS vaccines.
“The New York Department of Health has announced the next allocation plan for the JYNNEOS vaccine,” said the New York City Department of Health. statement July 21st. “As part of Phase 2b, approximately 26,000 additional doses from the federal government and state will be delivered to New York City through clinics, mass vaccination sites, and community-based referrals. Individuals will be distributed from July 24th to 8th. You can book appointments up to the 13th of March. “
Meanwhile, officials say Europe is the epicenter of the monkeypox epidemic. Ghebreyesus Said On Saturday, “The WHO assessment shows that the risk of monkeypox is moderate globally and in all regions except Europe, which is rated as high risk.”
But last week, the CDC confirmed the first cases of children in two separate states. It is not clear how the children were infected with the virus.
follow
Jack Phillips is the latest news reporter for The Epoch Times, based in New York.